Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Januar 2024

Biotek-snakken — Januar 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
110 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    Kennethl
    wrote on sidst redigeret af
    #87

    Tak exitnu! Virker godt nok som en hovedløs emission i mine øjne, ens nuværende aktier er jo ingen ting værd.

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #88

      JA, aktien er kun noget værd hvis du går med på emissionen. Pest eller kolera: vælg mellem at nedskrive til nul, eller påtag dig en ny risiko ...

      1 Reply Last reply
      0
      • K Offline
        K Offline
        Kennethl
        wrote on sidst redigeret af
        #89

        Har reduceret 50% overvejer det hele for aktien vil nok blive ved med at falde ned til de 0,3?

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #90

          Top Picks: Two smaller adjustments before the earnings season

          ... Increasing in Calliditas (from 3.3% of the portfolio to 7%) ...

          Just a moment...

          favicon

          (www.redeye.se)

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #91

            "Redeye’s base case is SEK280 and the share price is around SEK122."

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #92

              Lidt nyt fra Ascelia Pharma. 24 Jan. https://www.ascelia.com/mfn_news/orviglance-review-article-published-in-investigative-radiology/

              1 Reply Last reply
              0
              • F Offline
                F Offline
                Fandel
                wrote on sidst redigeret af
                #93

                Ja det har været nogle gode dage...

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #94

                  Video - Steg 220% på kun 3 dage - og jeg har aktien (Evaxion)!
                  https://www.proinvestor.com/boards/118268

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #95

                    Calliditas: Vera Therapeutics has released interesting additional 2b results

                    Just a moment...

                    favicon

                    (www.redeye.se)

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #96

                      "Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories."

                      Link Preview Image
                      Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO® - Calliditas Therapeutics AB | Renee Aguiar-Lucander

                      Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories. https://lnkd.in/dbqhAd_W

                      favicon

                      LinkedIn (www.linkedin.com)

                      1 Reply Last reply
                      0
                      • F Offline
                        F Offline
                        Fandel
                        wrote on sidst redigeret af
                        #97

                        Godmorgen...

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #98

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            LP90
                            wrote on sidst redigeret af
                            #99

                            Godmorgen 🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #100

                              Gode nyheder fra alligator bio. https://alligatorbioscience.se/en/news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #101

                                Alligator Bio har succes med deres CD40 monoclonale antistof Mitazalimab, så lad os håbe Genmab kan toppe den:

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #102

                                  Link Preview Image
                                  Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience

                                  Top-line readout demonstrates Objective Response Rate of 40.4%, meeting primary endpoint and confirming the benefit of mitazalimab in combin ...

                                  favicon

                                  (alligatorbioscience.se)

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    Kjølstad
                                    wrote on sidst redigeret af
                                    #103

                                    Nogen der ved, hvad der sker i IRLAB AB for tiden. Den sidste måned er den steget med 100%? (Er gået ind i dag med en lille slat spillemønter) 🙂

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      Kjølstad
                                      wrote on sidst redigeret af
                                      #104

                                      PS: De er ved at afslutte et fase II-forsøg og har en aftale med FDA om et møde for opsætning af fase III-forsøg https://irlab.se/newsroom/pressrelease-archive/, men det i sig selv er vel ikke tilstrækkeligt til så stor en stigning?

                                      1 Reply Last reply
                                      0
                                      • O Offline
                                        O Offline
                                        oge
                                        wrote on sidst redigeret af
                                        #105

                                        Iterum? Nå en kan jo ikke vinde hver gang?

                                        1 Reply Last reply
                                        0
                                        • O Offline
                                          O Offline
                                          oge
                                          wrote on sidst redigeret af
                                          #106

                                          Hvor "dum" kan man være, det går jo stygende der i Iterum!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper